Truman Hunt - Nu Skin CEO and President and Director

NUS Stock  USD 13.75  0.91  7.09%   

CEO

Mr. M. Truman Hunt is no longer Vice Chairman of the Board of the Company., effective June 30, 2017. He also joined our board of directors when he was named Chief Executive Officer. Mr. Hunt has served in various positions with our company since 1994, including Executive Vice President from 2001 to 2003 and General Counsel from 1996 to 2003. From 2005 until 2008, Mr. Hunt served as chairman of the World Federation of Direct Selling Associations, a global trade association for the direct selling industry
Age 56
Address 75 West Center Street, Provo, UT, United States, 84601
Phone801 345 1000
Webhttps://www.nuskin.com
Hunt also served as chairman of the board of directors for the United States Direct Selling Association from 2014 to 2015. He received a B.S. degree from Brigham Young University and a J.D. degree from the University of Utah.

Nu Skin Management Efficiency

The company has Return on Asset of 0.0461 % which means that on every $100 spent on assets, it made $0.0461 of profit. This is way below average. Nu Skin's management efficiency ratios could be used to measure how well Nu Skin manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to 0.04 in 2024. Return On Assets is likely to drop to 0 in 2024. Asset Turnover is likely to gain to 1.84 in 2024, whereas Total Assets are likely to drop slightly above 1.2 B in 2024.
The company has 607.33 M in debt with debt to equity (D/E) ratio of 0.59, which is OK given its current industry classification. Nu Skin Enterprises has a current ratio of 2.25, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Nu Skin until it has trouble settling it off, either with new capital or with free cash flow. So, Nu Skin's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Nu Skin Enterprises sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NUS to invest in growth at high rates of return. When we think about Nu Skin's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 5 records

CEO Age

Mitchell SteinerVeru Inc
54
Ma FranciscoProcter Gamble
52
Shailesh JejurikarProcter Gamble
57
Martin RiantProcter Gamble
55
Fama FranciscoProcter Gamble
50
Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah. Nu Skin operates under Household Personal Products classification in the United States and is traded on New York Stock Exchange. It employs 4600 people. Nu Skin Enterprises (NUS) is traded on New York Stock Exchange in USA. It is located in 75 West Center Street, Provo, UT, United States, 84601 and employs 3,700 people. Nu Skin is listed under Personal Care Products category by Fama And French industry classification.

Management Performance

Nu Skin Enterprises Leadership Team

Elected by the shareholders, the Nu Skin's board of directors comprises two types of representatives: Nu Skin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NUS. The board's role is to monitor Nu Skin's management team and ensure that shareholders' interests are well served. Nu Skin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nu Skin's outside directors are responsible for providing unbiased perspectives on the board's policies.
Scott Pond, Director - Investor Relations
Ritch Wood, CFO, Principal Accounting Officer and VP
Zhequing Shen, Director
Chayce Clark, Executive Vice President General Counsel
Joseph Chang, Executive Vice President - Product Development, Chief Scientific Officer
Emma Battle, Director
Thomas Pisano, Independent Director
Neil Offen, Independent Director
Mark Adams, Chief Officer
Zheqing Shen, Independent Director
James Thomas, Chief Accounting Officer
Mang Tang, Strategic Advisor
Joe Sueper, Senior CTO
Nevin Andersen, Independent Director
Mark Lawrence, Chief Financial Officer, Executive Vice President
Sandra Tillotson, Founder
D Dorny, Executive Vice President, General Counsel, Secretary
Daniel Campbell, Lead Independent Director
Edwina Woodbury, Independent Director
Truman Hunt, CEO and President and Director
Laura Nathanson, Independent Director
Steven Lund, Executive Chairman of the Board
Matthew Dorny, VP, General Counsel and Secretary
Connie Tang, Executive Vice President Chief Global Growth & customer Experience Officer
Scott Schwerdt, President - Americas Region
Blake Roney, Founder
Andrew Lipman, Independent Director
Ryan Napierski, President, Chief Executive Officer, Director

NUS Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nu Skin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nu Skin Enterprises is a strong investment it is important to analyze Nu Skin's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nu Skin's future performance. For an informed investment choice regarding NUS Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nu Skin Enterprises. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for NUS Stock analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Money Managers
Screen money managers from public funds and ETFs managed around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Is Nu Skin's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nu Skin. If investors know NUS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nu Skin listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.88)
Dividend Share
1.56
Earnings Share
0.17
Revenue Per Share
39.612
Quarterly Revenue Growth
(0.07)
The market value of Nu Skin Enterprises is measured differently than its book value, which is the value of NUS that is recorded on the company's balance sheet. Investors also form their own opinion of Nu Skin's value that differs from its market value or its book value, called intrinsic value, which is Nu Skin's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nu Skin's market value can be influenced by many factors that don't directly affect Nu Skin's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nu Skin's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nu Skin is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nu Skin's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.